The endothelial PECAM1-CXCR4 axis amplifies neutrophil degranulation to exacerbate sleep-deprived periodontitis: a systems-level framework for comorbidity therapy
Authors: Liu, Kehao; Yang, Mingcong; Hu, Xuehui; Chen, Tao; Huang, Qi; Xie, Ying; Li, Yuzhou; Yang, Sheng
Source journal: Cell communication and signaling : CCS (2026-08-20)
DOI: 10.1186/s12964-026-03156-9
Abstract
BACKGROUND: Sleep deprivation (SD), a global public health issue, induces systemic low-grade inflammation and vascular endothelial dysfunction, and is a confirmed risk factor for periodontitis (PD). PD is driven by vascular-immune imbalance and excessive neutrophil activation/degranulation, yet the molecular mechanism linking SD-induced systemic changes to local periodontal inflammation remains unclear, leaving a lack of precise therapeutic targets for SD-PD comorbidity. METHODS: Here, we conducted a systems-level study integrating population epidemiology (NHANES/KNHANES), clinical sample validation, multi-omics bioinformatics analysis, and in vitro/in vivo models. We screened SD-PD core hub genes via WGCNA, DEG and disease target mining, elucidated their regulatory role in neutrophil degranulation with cellular models, and identified candidate dual-target agents by molecular docking/MDS, then validated the candidate drug's efficacy in SD-PD comorbidity mice with multiple detection techniques. RESULTS: We first confirmed in human cohorts and mouse models that SD exacerbates neutrophil-mediated periodontal bone loss. Integrative bioinformatic analysis pinpointed endothelial PECAM1 and neutrophil CXCR4 as key molecules. Mechanistically, we reveal that under inflammatory conditions, endothelial PECAM1 can physically interact with CXCL12, potentially acting as a molecular sink that influences its local availability. This ligand scarcity triggers a compensatory upregulation of its receptor, CXCR4, on neutrophils. Consequently, these primed neutrophils become hyper-reactive, leading to excessive degranulation and tissue destruction upon stimulation. Leveraging this mechanism, we computationally identified and experimentally validated curcumin as a dual-functional modulator of PECAM1 and CXCR4. In our comorbidity mouse model, curcumin not only blocked this pathological axis to mitigate periodontal destruction but also associated with partial recovery of NREM sleep architecture, possibly through mitigation of systemic inflammation. Our findings establish the PECAM1-CXCR4 axis as a critical, druggable pathway in sleep-inflammation comorbidity and provide a conceptual framework for treating complex systemic-local disorders.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.